StoneX Sees Record Q3 as IMAX Stock Hits Analyst Ceiling
StoneX reiterated a Buy on IMAX and forecast a record third quarter—a call that lands just as the stock trades at $51.70 against an analyst consensus target of $52.73, implying less than 2% upside. Fo
StoneX Sees Record Q3 as IMAX Stock Hits Analyst Ceiling
NEW YORK, September 2 —
IMAX Corporation (IMAX) stock sits within $1.03 of the analyst consensus target after four consecutive earnings beats, precisely the moment, per SEC filings, when the CEO liquidated nearly $24 million in shares. StoneX reiterated Buy and forecast a record third quarter, but at $51.70 against a $52.73 consensus target, the optimism is already priced before Q3 reports a single number.
- Four straight EPS beats; most recent at $0.43 vs. $0.27 estimated, a 59.1% upside surprise.
- CEO Richard Gelfond sold 456,757 shares totaling $23.98 million across three consecutive days in August, per SEC filings.
- Short interest stands at 20.0% of the float; an earnings miss would amplify the decline.
Analysts Have Already Priced the Good News
IMAX digitally re-masters Hollywood films through its proprietary DMR technology and distributes them to commercial multiplexes, science museums, and themed venues worldwide. Its bull case rests on real fundamentals: trailing revenue up 12.2% to $0.42 billion, gross margin at 59.7%, and $109 million in free cash flow. Run those inputs through a DCF calculator and the 3.8% FCF yield against a $2.84 billion market cap looks reasonable at today's price. The problem: the "moderate buy" consensus at a 25x forward earnings multiple and a $52.73 target has already absorbed the optimism before a single Q3 number is filed.
When Management Sells at the Peak
Between August 18 and 20, CEO Richard Gelfond executed three open-market sales, per SEC filings: 151,253 shares at $51.00, 205,504 at $53.27, and 100,000 at $53.23. The sales followed option exercises at a $31.90 strike that generated roughly $11 million in gains. CFO Natasha Fernandes sold $1.09 million on August 24; President of IMAX Global Theatres Mark Welton sold $1.63 million on August 25. Combined net selling over 90 days: $27.96 million, zero insider purchases. The pattern, three senior executives selling at the stock's recent highs, is hard to dismiss as routine tax planning.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| IMAX | $2.8B | 25.0x | +74.9% |
| CNK | $4.1B | 13.4x | +37.0% |
| LYV | $41.8B | 95.1x | +9.4% |
| PLAY | $325M | n/a | -65.1% |
| AMCX | $522M | 4.6x | +69.5% |
| MCS | $866M | 33.4x | +83.4% |
Q3 Is the Tell
The setup is asymmetric in both directions. A "record" Q3 requires analysts to ratchet targets above the current consensus ceiling, no sure thing at a 25x earnings multiple already priced for success. A miss, meanwhile, lands against 20.0% short interest, turning any disappointment into a forced-exit event, not a measured repricing. IMAX carries $120 million in net debt against $160 million in cash, a manageable position, but a 59.1% beat last quarter set expectations that compound the cost of any shortfall. Run the free IMAX Corporation deep-dive → for updated numbers before Q3 reports.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
StoneX reiterated a Buy on IMAX and forecast a record third quarter—a call that lands just as the stock trades at $51.70 against an analyst consensus target of $52.73, implying less than 2% upside. Four consecutive earnings beats have driven IMAX to all-time highs, but the analyst community's math suggests the run is already priced.